The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma.
Saved in:
| Title: | The tumor suppressor BAP1 cooperates with BRAFV600E to promote tumor formation in cutaneous melanoma. |
|---|---|
| Authors: | Webster JD; Department of Pathology, Genentech, Inc., South San Francisco, California., Pham TH; Department of Discovery Oncology, Genentech, Inc., South San Francisco, California., Wu X; Department of Translational Immunology, Genentech, Inc., South San Francisco, California., Hughes NW; Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Li Z; Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California.; Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China., Totpal K; Department of Translational Oncology, Genentech, Inc., South San Francisco, California., Lee HJ; Department of Discovery Oncology, Genentech, Inc., South San Francisco, California., Calses PC; Department of Discovery Oncology, Genentech, Inc., South San Francisco, California., Chaurushiya MS; Department of Physiological Chemistry, Genentech, Inc., South San Francisco, California., Stawiski EW; Department of Molecular Biology, Genentech, Inc., South San Francisco, California., Modrusan Z; Department of Molecular Biology, Genentech, Inc., South San Francisco, California., Chang MT; Department of Bioinformatics, Genentech, Inc., South San Francisco, California., Tran C; Department of Discovery Oncology, Genentech, Inc., South San Francisco, California., Lee WP; Department of Translational Immunology, Genentech, Inc., South San Francisco, California., Chalasani S; Department of Pathology, Genentech, Inc., South San Francisco, California., Hung J; Department of Pathology, Genentech, Inc., South San Francisco, California., Sharma N; Department of Pathology, Genentech, Inc., South San Francisco, California., Chan S; Department of Pathology, Genentech, Inc., South San Francisco, California., Hotzel K; Department of Pathology, Genentech, Inc., South San Francisco, California., Talevich E; Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Shain A; Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Xu M; Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Lill J; Department of Microchemistry, Proteomics and Lipidomics, Genentech, Inc., South San Francisco, California., Dixit VM; Department of Physiological Chemistry, Genentech, Inc., South San Francisco, California., Bastian BC; Departments of Dermatology and Pathology and Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, California., Dey A; Department of Discovery Oncology, Genentech, Inc., South San Francisco, California. |
| Source: | Pigment cell & melanoma research [Pigment Cell Melanoma Res] 2019 Mar; Vol. 32 (2), pp. 269-279. Date of Electronic Publication: 2018 Sep 24. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Blackwell Munksgaard Country of Publication: England NLM ID: 101318927 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-148X (Electronic) Linking ISSN: 17551471 NLM ISO Abbreviation: Pigment Cell Melanoma Res |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1755-148X |
|---|---|
| DOI: | 10.1111/pcmr.12735 |
